Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 7Completed 4Recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 151INDUSTRY 72OTHER_GOV 4NIH 3NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 196Breast 124Gynecologic 68Thoracic 47Head & Neck 46Genitourinary 46Lymphoid 32Tumor-Agnostic 25Other hematologic neoplasm 23CNS 21Dermatologic 18Sarcoma 12Other 11Endocrine 10Plasma cell 9Other solid neoplasm 9Myeloid 6NET 4Classical hematology 4Other neoplasm 1

Conditions

Neuroendocrine Tumors 4Thymoma 1Mesothelioma 1Hypersensitivity 1

Interventions

olaparib 1copper dotatate CU-64 1Lutetium-177 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × NET × Clear all
NCT04375267 2026-04-14

LuPARP

Vastra Gotaland Region

Phase 1 Completed
18 enrolled
EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Azienda USL Reggio Emilia - IRCCS

Phase 2 Completed
142 enrolled
EndocrineNET

Hypersensitivity, Neuroendocrine Tumors

NCT03840720 2020-04-28

The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET

Vastra Gotaland Region

Completed
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02125474 2019-11-14

Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate

Instituto Nacional de Cancerologia, Columbia

Phase NA Completed
39 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡